A stability of ILD lesions and PFTS was observed in patients with baseline KL-6 <655 UI/mL (25th percentile value in French patients with RA-ILD) (Table 4), whereas ILD progression was detected on patients with higher serum KL-6 concentrations (Fig 1F, Table 4). The gene discussed is MUC1; the disease is rheumatoid arthritis.